UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Reply to Black and Ford

The American journal of gastroenterology, 2021-02, Vol.116 (2), p.429-429

Plasse, Terry F

2021

Volltextzugriff (PDF)

A randomized, placebo-controlled pilot study of upamostat, a host-directed serine protease inhibitor, for outpatient treatment of COVID-19

International journal of infectious diseases, 2023-03, Vol.128, p.148-156

2023

Volltextzugriff (PDF)

Bimodal Release Ondansetron Improves Stool Consistency and Symptomatology in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Trial

The American journal of gastroenterology, 2020-09, Vol.115 (9), p.1466-1473

2020

Volltextzugriff (PDF)

Recent Progress in the Development of Opaganib for the Treatment of Covid-19

Drug design, development and therapy, 2022-01, Vol.16, p.2199-2211

2022

Volltextzugriff (PDF)

Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease

Gastroenterology (New York, N.Y. 1943), 2002-01, Vol.122 (1), p.7-14

2002

Volltextzugriff (PDF)

Bimodal Release Ondansetron for Acute Gastroenteritis Among Adolescents and Adults: A Randomized Clinical Trial

JAMA network open, 2019-11, Vol.2 (11), p.e1914988-e1914988

2019

Volltextzugriff (PDF)

Phase II Trial of Interleukin 2, Interferon α, and 5-Fluorouracil in Metastatic Renal Cell Cancer: A Cytokine Working Group Study

Clinical cancer research, 2000-09, Vol.6 (9), p.3442-3450

2000

Volltextzugriff (PDF)

Misoprostol dose selection in a controlled-release vaginal insert for induction of labor in nulliparous women

American journal of obstetrics and gynecology, 2005-09, Vol.193 (3), p.1071-1075

2005

Volltextzugriff (PDF)

Phase II trial of opaganib in patients with metastatic castration-resistant prostate cancer progressing on abiraterone or enzalutamide (NCT04207255)

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.TPS191-TPS191

2021

Volltextzugriff (PDF)

Su1188 - Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of Ondansetron 12 Mg Bimodal Release Tablets for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-498-S-498

2018

Volltextzugriff (PDF)

A Phase I Study of CNI-1493, an Inhibitor of Cytokine Release, in Combination with High-Dose Interleukin-2 in Patients with Renal Cancer and Melanoma

Clinical cancer research, 2001-03, Vol.7 (3), p.486-492

2001

Volltextzugriff (PDF)

Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma

Annals of hematology, 2023-02, Vol.102 (2), p.369-383

2023

Volltextzugriff (PDF)

Absence of QT prolongation after administration of a 24-mg bimodal-release ondansetron pill (RHB-102)

The American journal of emergency medicine, 2021-05, Vol.43, p.205-209

2021

Volltextzugriff (PDF)

Abstract 4200: New potential therapeutic applications of WX-UK1, as a specific and potent inhibitor of human trypsin-like proteases

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4200-4200

2018

Volltextzugriff (PDF)

Abstract B055: New potential therapeutic applications of WX-UK1 as a specific and potent inhibitor of human trypsin-2 and human trypsin-3

Molecular cancer therapeutics, 2018-01, Vol.17 (1_Supplement), p.B055-B055

2018

Volltextzugriff (PDF)

A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy

Obstetrics and gynecology (New York. 1953), 2003-03, Vol.101 (3), p.469-479

2003

Volltextzugriff (PDF)

A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease

Gut, 2010-06, Vol.59 (6), p.760-766

2010

Volltextzugriff (PDF)

ASN002: A Potent Dual SYK/JAK Inhibitor Currently in a Phase I/II Study Shows Strong Antitumor Activity in Preclinical Studies

Blood, 2015-12, Vol.126 (23), p.4009-4009

2015

Volltextzugriff (PDF)

Natural interferon alfa for treatment of condylomata acuminata

JAMA : the journal of the American Medical Association, 1988-01, Vol.259 (4), p.533

1988

Volltextzugriff (PDF)

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS

Journal of pain and symptom management, 1995-02, Vol.10 (2), p.89-97

1995

Volltextzugriff (PDF)

Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia

Journal of pain and symptom management, 1997-07, Vol.14 (1), p.7-14

1997

Volltextzugriff (PDF)

1,25-dihydroxyvitamin D3 receptors in human carcinomas : a pilot study

Cancer research (Chicago, Ill.), 1991-04, Vol.51 (8), p.2021-2024

1991

Volltextzugriff (PDF)

Misoprostol controlled-release vaginal insert for cervical ripening and induction of labor in nulliparous women

American journal of obstetrics and gynecology, 2004-12, Vol.191 (6), p.S187-S187

2004

Volltextzugriff (PDF)

Recent clinical experience with dronabinol

Pharmacology Biochemistry and Behavior [PHARMACOL., BIOCHEM. BEHAV.]. Vol. 40, no. 3. 1991, 1991-11, Vol.40 (3), p.695-700

1991

Volltextzugriff (PDF)

Pharmacokinetics of a Controlled-Release Misoprostol Vaginal Insert at Term

Journal of the Society for Gynecologic Investigation, 2006-02, Vol.13 (2), p.112-117

2006

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(29)
Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Biological And Medical Sciences
(18)
Female
(17)
Medical Sciences
(17)
Adult
(16)
Male
(14)
Middle Aged
(13)
Double-Blind Method
(12)
Pharmacology. Drug Treatments
(11)
Aged
(9)
Oncology
(8)
Dronabinol - Therapeutic Use
(5)
General & Internal Medicine
(5)
Medicine, General & Internal
(5)
Pharmacology & Pharmacy
(5)
Adolescent
(4)
Aids/hiv
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reply to Black and Ford

A randomized, placebo-controlled pilot study of upamostat, a host-directed serine protease inhibitor, for outpatient treatment of COVID-19

Bimodal Release Ondansetron Improves Stool Consistency and Symptomatology in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Trial

Recent Progress in the Development of Opaganib for the Treatment of Covid-19

Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease

Bimodal Release Ondansetron for Acute Gastroenteritis Among Adolescents and Adults: A Randomized Clinical Trial

Phase II Trial of Interleukin 2, Interferon α, and 5-Fluorouracil in Metastatic Renal Cell Cancer: A Cytokine Working Group Study

Misoprostol dose selection in a controlled-release vaginal insert for induction of labor in nulliparous women

Phase II trial of opaganib in patients with metastatic castration-resistant prostate cancer progressing on abiraterone or enzalutamide (NCT04207255)

Su1188 - Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of Ondansetron 12 Mg Bimodal Release Tablets for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

A Phase I Study of CNI-1493, an Inhibitor of Cytokine Release, in Combination with High-Dose Interleukin-2 in Patients with Renal Cancer and Melanoma

Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma

Absence of QT prolongation after administration of a 24-mg bimodal-release ondansetron pill (RHB-102)

Abstract 4200: New potential therapeutic applications of WX-UK1, as a specific and potent inhibitor of human trypsin-like proteases

Abstract B055: New potential therapeutic applications of WX-UK1 as a specific and potent inhibitor of human trypsin-2 and human trypsin-3

A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy

A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease

ASN002: A Potent Dual SYK/JAK Inhibitor Currently in a Phase I/II Study Shows Strong Antitumor Activity in Preclinical Studies

Natural interferon alfa for treatment of condylomata acuminata

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS

Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia

1,25-dihydroxyvitamin D3 receptors in human carcinomas : a pilot study

Misoprostol controlled-release vaginal insert for cervical ripening and induction of labor in nulliparous women

Recent clinical experience with dronabinol

Pharmacokinetics of a Controlled-Release Misoprostol Vaginal Insert at Term

Suchergebnisse filtern